PMA device
Impella Ventricular Support Systems
Abiomed, Inc. · Temporary Non-Roller Type Left Heart Support Blood Pump (OZD, Class III) · First FDA decision Apr 7, 2016, newest Mar 29, 2023Cardiogenic shock
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
8
PMA pathway
Device trials
28
Naming "Impella Ventricular"
MAUDE reports
0
Brand "Impella Ventricular", since 2015
PubMed studies
30
Mentioning "Impella Ventricular"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Impella Ventricular Support Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 8 decisions filed under this name.
- Impella Ventricular Support SystemsPMA supplement
P140003-S107 · Decided Mar 29, 2023 · 166 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella Ventricular Support SystemsPMA supplement
P140003-S083 · Decided Jul 13, 2021 · 71 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
- Impella Ventricular Support SystemsPMA supplement
P140003-S081 · Decided Jul 13, 2021 · 71 days after receipt · Normal 180 Day Track No User Fee
Device type: Temporary non-roller type left heart support blood pump (OZD) · Cardiology
3 more FDA decisions with a free account
Older decisions: P140003-S008, P140003-S004
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Impella Ventricular", any status and sponsor, newest update first.
- Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)Pivotal-lookingRecruiting
Supira MedicalNot on our public-company list
NCT07296744 · 358 participants (planned) · Start May 11, 2026 · Primary completion Nov 2027
Device: The Supira System; Impella · For: Coronary Artery Disease; High Risk Percutaneous Coronary Intervention; Interventional Cardiology and 1 more
Sites: Loma Linda, California; Sacramento, California; Thousand Oaks, California · 27 sites in all
- Left Ventricular Impella Device Real-World Evaluation in Pediatric PatientsActive, not recruiting
Abiomed Inc.Public (JNJ)
NCT07943182 · 60 participants (planned) · Start Dec 3, 2024 · Primary completion Dec 2027
Device: Impella CP with SmartAssist; Impella 5.5 with SmartAssist · For: Cardiogenic Shock; Heart Failure; Acute Decompensated Heart Failure (ADHF) and 2 more
Sites: Phoenix, Arizona; Loma Linda, California; Los Angeles, California · 24 sites in all
- Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockPivotal-lookingNot yet recruiting
Leipzig Heart Science gGmbHAcademic, hospital or other
NCT07762560 · 780 participants (planned) · Start May 1, 2027 · Primary completion Oct 2030
Device: Microaxial flow pump (left ventricular assist device); Pulmonary artery catheter · For: Cardiogenic Shock; Acute Myocardial Infarction (AMI); Heart Failure, Acute
Sites: Leipzig, Germany
25 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Impella Ventricular", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code OZD
46,892 reports: 17,926 malfunction, 23,020 injury, 5,943 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Automated Impella Controller, Packaged. Primary user control interface for the Impella Catheter, catheter-based heart pump.Open, Classified
Z-0208-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0209-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
- Impella Connect Optical AIC, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.Open, Classified
Z-0210-2027 · Started Sep 18, 2026 · Posted by FDA Oct 28, 2026
Reason given: Retrospective review of servicing records identified AIC units requiring various hardware, firmware, and/or software update(s): 1. RFID firmware issue that may result in failure of the AIC to recognize the purge cassette during case setup or cassette change. This issue may result in delay in procedure or therapy. 2....
Cause as FDA categorized it: Under Investigation by firm · Device type: Temporary Non-Roller Type Left Heart Support Blood Pump (OZD)
22 more recall records with a free account
Published research
The most relevant PubMed records for "Impella Ventricular"[tiab]. The summary above synthesizes these.
- Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group.
Burzotta F, Trani C, Doshi SN, et al. · Int J Cardiol · 2015Research Support, Non-U.S. Gov't, Review
- Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement.
Tarantini G, Nai Fovino L · Catheter Cardiovasc Interv · 2020Editorial, Comment
- Mechanical Circulatory Support: a Comprehensive Review With a Focus on Women.
Alasnag M, Truesdell AG, Williams H, et al. · Curr Atheroscler Rep · 2020Review
- Versatility of Impella® Ventricular Assist Devices in High-risk Cardiac Patients During Complex Procedures: A Case Series.
Swaminathan N, Hazelwood M, Odo N, et al. · J Innov Card Rhythm Manag · 2024Case Reports
- Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery.
Sicouri S, Shah VN, Buckley M, et al. · Braz J Cardiovasc Surg · 2023
- The effectiveness and safety of the Impella ventricular assist device for high-risk percutaneous coronary interventions: A systematic review.
Ait Ichou J, Larivée N, Eisenberg MJ, et al. · Catheter Cardiovasc Interv · 2018Systematic Review
- Protected Percutaneous Coronary Intervention of Unprotected Left Main Using Impella Ventricular Assist Device Before Transcatheter Aortic Valve Implantation: A Single-Center Experience.
Kneizeh K, Alnaimi A, Noterdaeme T, et al. · J Invasive Cardiol · 2022Observational Study
- Hemodynamic support with Impella ventricular assist device in patients undergoing TAVI: A single center experience.
Almalla M, Kersten A, Altiok E, et al. · Catheter Cardiovasc Interv · 2020Multicenter Study
- Initial Experience With the Pediatric Impella Device: A Feasibility Study in a Porcine Model.
Webb MK, Wang J, Riegel MS, et al. · Catheter Cardiovasc Interv · 2016
- Analysis of Bicarbonate-Based Purge Solution in Patients With Cardiogenic Shock Supported Via Impella Ventricular Assist Device.
Bergen K, Sridhara S, Cavarocchi N, et al. · Ann Pharmacother · 2023
- Short-term use of an Impella ventricular assist device sterile water-based bicarbonate purge solution for positron emission tomography scanning.
Schumacher SM, Hobbs RA · Am J Health Syst Pharm · 2024Case Reports
- Comment: Analysis of Bicarbonate-Based Purge Solution in Patients With Cardiogenic Shock Supported Via Impella Ventricular Device.
Moretz JD, Corbett S, Bilazarian S · Ann Pharmacother · 2023Letter, Comment
Other devices of this type
Also filed under product code OZD.
- Impella 2.5Abiomed, Inc. · PMA 2025
- Impella CP with SmartAssistAbiomed, Inc. · PMA 2025
- Impella 2.5, Impella CP and CP with SmartAssistAbiomed, Inc. · PMA 2023
- Impella 5.5 with SmartAssist, Impella CP with SmartAssist, Purge CassetteAbiomed, Inc. · PMA 2025
- Impella Left Ventricular Support SystemsAbiomed, Inc. · PMA 2021
- Automated Impella ControllerAbiomed, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.